• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Amgen

Amgen

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. FDA Rejects Amgen Hormonal-Imbalance Treatment

    FDA Rejects Amgen Hormonal-Imbalance Treatment

  2. FDA Rejects Amgen Hormonal-Imbalance Treatment

    FDA Rejects Amgen Hormonal-Imbalance Treatment

  3. UPDATE: Mylan offers price plan to help patients but its programs are still short on details

    UPDATE: Mylan offers price plan to help patients but its programs are still short on details

  4. Osteoporosis Companies Drugs (Merck, Sanofi, Novartis, Eli Lilly and Amgen ) Sales & Forecast 2010-2019 - Research and Markets

    Osteoporosis Companies Drugs (Merck, Sanofi, Novartis, Eli Lilly and Amgen ) Sales & Forecast 2010-2019 - Research and Markets

  5. UPDATE: Bull trend intact, latest S&P 500 breakout attempt underway

    UPDATE: Bull trend intact, latest S&P 500 breakout attempt underway

  6. UPDATE: Bull trend intact, latest S&P 500 -2-

    UPDATE: Bull trend intact, latest S&P 500 -2-

  7. Bull trend intact, latest S&P 500 breakout -2-

    Bull trend intact, latest S&P 500 breakout -2-

  8. Bull trend intact, latest S&P 500 breakout attempt underway

    Bull trend intact, latest S&P 500 breakout attempt underway

  9. Fitch Rates Amgen Inc.'s Notes Offering 'BBB'

    Fitch Rates Amgen Inc.'s Notes Offering 'BBB'

  10. AbbVie Sues Amgen Over Humira

    AbbVie Sues Amgen Over Humira

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.